Backing the breakthroughs of tomorrow
Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.
Venture capital and biotechnology
Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide fostering a positive impact on patients and society.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 29 Feb 2024 | | |
MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Sep 2023 | | |
Gimv Financial Services | Gimv Financial Services | Other 20 May 2023 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 6 Jun 2023 | | |
Estimeo Consulting, Information Services | Estimeo Consulting, Information Services | Other 19 Sep 2022 | | |
Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 31 Jan 2023 | |